TOCQUEVILLE ASSET MANAGEMENT L.P. - Chelsea Therapeutics Contingen ownership

Chelsea Therapeutics Contingen's ticker is and the CUSIP is 163ESC908. A total of 1 filers reported holding Chelsea Therapeutics Contingen in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of Chelsea Therapeutics Contingen
ValueSharesWeighting
Q1 2018$080,0000.0%0.00%
Q4 2017$080,0000.0%0.00%
Q3 2017$080,0000.0%0.00%
Q2 2017$080,0000.0%0.00%
Q1 2017$080,0000.0%0.00%
Q4 2016$080,0000.0%0.00%
Q3 2016$080,0000.0%0.00%
Q2 2016$080,0000.0%0.00%
Q1 2016$080,0000.0%0.00%
Q4 2015$080,0000.0%0.00%
Q3 2015$080,0000.0%0.00%
Q2 2015$080,0000.0%0.00%
Q4 2014$080,0000.0%0.00%
Q2 2014$080,0000.00%
Other shareholders
Chelsea Therapeutics Contingen shareholders Q1 2017
NameSharesValueWeighting ↓
PARAMETRIC PORTFOLIO ASSOCIATES LLC 26,487$00.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 80,000$00.00%
View complete list of Chelsea Therapeutics Contingen shareholders